THERAPEUTICS
Ondansetron reduced the need for intravenous hydration in children with acute gastritis/gastroenteritis and dehydration
| The first 150 words of the full text of this article appear below. |
G Roslund
Dr G Roslund, St Joseph Regional Medical Center, South Bend, IN, USA; groslund@hotmail.com
STUDY DESIGN
randomised, placebo-controlled trial.
concealed.*
blinded (patients, parents, healthcare providers, outcome assessors, and data collectors).*
STUDY QUESTION
emergency department (ED) of a hospital in Chicago, USA.
106 children 1–10 years of age (mean age 4 y, 56% girls) who had a clinical diagnosis of acute gastritis/gastroenteritis (AGE) with mild or moderate dehydration and failed oral rehydration in the ED. Children who had received an antiemetic agent in <6 hours, had a chronic illness, or were in shock were excluded.
2, 4, or 6 mg ondansetron as orally dissolving tablets (for children weighing <15, 15–30, or >30 kg, respectively) (n = 51) or placebo (n = 55). Oral rehydration was reattempted 30 minutes later. Children who tolerated the oral challenge were discharged after drinking 40 ml/kg over 2 hours. Children who failed the oral challenge (vomited or refused liquids)
University of Western Ontario London, Ontario, Canada
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
